Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jean‐Michel Luccarini
Observed names:
J M Luccarini,
J ‐M Luccarini,
J.-M. Luccarini,
J.M. Luccarini,
J.‐M. Luccarini,
JM Luccarini,
Jean-Michel Luccarini,
Luccarini, Jean-Michel
show all 8
Institution:
Inventiva (France)
Observed institutions:
Centre National de la Recherche Scientifique,
Inserm,
Université Joseph Fourier,
Université de Montpellier,
Centre de Biologie Structurale,
Inventiva (France)
show all 6
OpenAlex ID:
A5111793045
The new‐generation pan‐peroxisome proliferator‐activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis
2017
·
Guillaume Wettstein
, Jean‐Michel Luccarini
, et al.
·
Hepatology Communications
·
140
Design, Synthesis, and Evaluation of a Novel Series of Indole Sulfonamide Peroxisome Proliferator Activated Receptor (PPAR) α/γ/δ Triple Activators: Discovery of Lanifibranor, a New Antifibrotic Clinical Candidate
2018
·
Benaïssa Boubia
, Olivia Poupardin
, et al.
·
Journal of Medicinal Chemistry
·
120
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis
2016
·
Nadira Ruzehaji
, Camelia Frantz
, et al.
·
Annals of the Rheumatic Diseases
·
105
PDF
Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension
2017
·
Jerome Avouac
, Irena Konstantinova
, et al.
·
Annals of the Rheumatic Diseases
·
80
CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas
2022
·
Leticia Laura Niborski
, Paul Gueguen
, et al.
·
Nature Communications
·
74
PDF
Design and Synthesis of Potent Bradykinin Agonists Containing a Benzothiazepine Moiety
1999
·
Muriel Amblard
, Isabelle Daffix
, et al.
·
Journal of Medicinal Chemistry
·
65
Antinociceptive Pharmacology of N-[[4-(4,5-Dihydro-1 H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl) sulfonyl]methylamino]ethoxy]-N-methylacetamide, Fumarate (LF22-0542), a Novel Nonpeptidic Bradykinin B1 Receptor Antagonist
2006
·
F. Porreca
, T.W. Vanderah
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
53
Induction of kinin B1 receptor‐dependent vasoconstriction following balloon catheter injury to the rabbit carotid artery
1994
·
D. Pruneau
, J.M. Luccarini
, et al.
·
British Journal of Pharmacology
·
51
PDF
LF 16.0335, a novel potent and selective nonpeptide antagonist of the human bradykinin B2 receptor
1998
·
Didier Pruneau
, Jean‐Michel Luccarini
, et al.
·
British Journal of Pharmacology
·
31
PDF
Synthesis and Characterization of Bradykinin B2 Receptor Agonists Containing Constrained Dipeptide Mimics
1999
·
Muriel Amblard
, Isabelle Daffix
, et al.
·
Journal of Medicinal Chemistry
·
30
A Rational Approach to the Design and Synthesis of a New Bradykinin B1 Receptor Antagonist
2000
·
Philippe Bedos
, Muriel Amblard
, et al.
·
Journal of Medicinal Chemistry
·
28
Pharmacological characterization of the bradykinin B2 receptor: inter‐species variability and dissociation between binding and functional responses
1999
·
J ‐L Paquet
, J ‐M Luccarini
, et al.
·
British Journal of Pharmacology
·
28
PDF
Characterisation of bradykinin receptors from juvenile pig coronary artery
1996
·
Didier Pruneau
, Jean-Michel Luccarini
, et al.
·
European Journal of Pharmacology
·
28
Pharmacological evidence for a single bradykinin B 2 receptor in the guinea‐pig
1995
·
D. Pruneau
, J.M. Luccarini
, et al.
·
British Journal of Pharmacology
·
27
PDF
Pharmacological and molecular evidence for kinin B1 receptor expression in urinary bladder of cyclophosphamide‐treated rats
1999
·
P Belichard
, J M Luccarini
, et al.
·
British Journal of Pharmacology
·
24
PDF
Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI—Evidence from in vitro and in vivo models
2020
·
Eugeni Entchev
, Ingrid Jantzen
, et al.
·
PLoS ONE
·
23
PDF
Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists
2019
·
Jérôme Amaudrut
, Maria A. Argiriadi
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
22
From Bradykinin B2 Receptor Antagonists to Orally Active and Selective Bradykinin B1 Receptor Antagonists
2012
·
Martine Barth
, Michel Bondoux
, et al.
·
Journal of Medicinal Chemistry
·
15
Synthesis and Biological Evaluation of Bradykinin B1/B2 and Selective B1 Receptor Antagonists
2000
·
Muriel Amblard
, Philippe Bedos
, et al.
·
Journal of Medicinal Chemistry
·
15
Inhibition of Interleukin-23–Mediated Inflammation with a Novel Small Molecule Inverse Agonist of RORγt
2019
·
Stephen B. Gauld
, Sebastien Jacquet
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
14
PDF
Cloning and characterization of guinea pig interleukin-8 receptor
2003
·
Julie Catusse
, Patrick Faye
, et al.
·
Biochemical Pharmacology
·
13
The kinin B1 receptor antagonist des‐Arg9‐[Leu8]bradykinin: an antagonist of the angiotensin AT1 receptor which also binds to the AT2 receptor
1995
·
D. Pruneau
, A. Duvoid
, et al.
·
British Journal of Pharmacology
·
13
PDF
In vitro and in vivo effects of the new nonpeptide bradykinin B2receptor antagonist, LF 16‐0335C, on guinea‐pig and rat kinin receptors
1999
·
Didier Pruneau
, Jean‐Michel Luccarini
, et al.
·
Fundamental and Clinical Pharmacology
·
11
Synthesis and pharmacological evaluation of dimer derivatives of the bradykinin receptor antagonist HOE‐140
1998
·
I. Daffix
, M. Amblard
, et al.
·
Journal of Peptide Research
·
9
Specific Nonpeptide Photoprobes as Tools for the Structural Study of the Angiotensin II AT1 Receptor
1999
·
Sandrine Nouet
, Pierre R. Dodey
, et al.
·
Journal of Medicinal Chemistry
·
5
Show more works
View as search
Works count:
35
Citation count:
1,034
H-index:
17
I10-index:
23
Year
Topic
Type